Inhibition of bactericidal activity of anticapsular antibody by nonspecific antibodies reactive with surface-exposed antigenic determinants on Actinobacillus pleuropneumoniae
- PMID: 1379990
- PMCID: PMC257399
- DOI: 10.1128/iai.60.9.3852-3860.1992
Inhibition of bactericidal activity of anticapsular antibody by nonspecific antibodies reactive with surface-exposed antigenic determinants on Actinobacillus pleuropneumoniae
Abstract
In an attempt to understand the mechanism of serum resistance in Actinobacillus pleuropneumoniae, in the present study we examined various interactions among the bacterial surface constituents, serum antibodies, and complement. Analysis of swine sera revealed the presence of anticapsular antibodies in convalescent-phase sera but not in preimmune sera. Both types of sera contained antibodies which reacted with each of 14 polypeptides present in saline extracts of the bacteria. Absorption of the preimmune sera with intact bacteria depleted antibodies to two of the polypeptides (27 and 32 kDa) and high-molecular-weight (greater than 97.4,000) components which did not stain with Coomassie blue. Data derived from complement consumption and C3-binding experiments indicated that the organism was capable of initiating complement activation and binding C3 during incubation in preimmune and immune sera. Experiments designed to evaluate the bactericidal effectiveness of anticapsular antibody revealed that the purified antibody was bactericidal only when preimmune sera absorbed with intact bacteria were used as a source of complement. The bactericidal effects of anticapsular antibody and absorbed preimmune sera were inhibited in a dose-dependent manner by heat-inactivated preimmune sera and immunoglobulin G derived from the sera. The inhibitory activity of the preimmune sera was neutralized by preincubating the sera with column fractions of the saline extract which contained either the 27- or the 32-kDa polypeptide. These results indicate that serum resistance in A. pleuropneumoniae 4074 could be related to inhibition of the bactericidal action of anticapsular antibody by nonspecific antibodies which recognize surface-exposed epitopes on the polypeptides.
Similar articles
-
Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.J Immunol. 1994 Sep 1;153(5):2110-21. J Immunol. 1994. PMID: 8051416
-
Antigenic differences within Actinobacillus pleuropneumoniae serotype 1.Vet Microbiol. 1994 Feb;38(4):329-49. doi: 10.1016/0378-1135(94)90151-1. Vet Microbiol. 1994. PMID: 8160348
-
Characterization of monoclonal antibodies against Actinobacillus pleuropneumoniae serotype 5.Am J Vet Res. 1992 Sep;53(9):1519-23. Am J Vet Res. 1992. PMID: 1384404
-
Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.Int J Med Microbiol. 2002 Jun;291 Suppl 33:141-6. doi: 10.1016/s1438-4221(02)80027-3. Int J Med Microbiol. 2002. PMID: 12141738 Review.
-
Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.Anim Health Res Rev. 2000 Dec;1(2):73-93. doi: 10.1017/s1466252300000074. Anim Health Res Rev. 2000. PMID: 11708600 Review.
Cited by
-
Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host.Vet Res. 2010 Sep-Oct;41(5):65. doi: 10.1051/vetres/2010037. Epub 2010 Jun 15. Vet Res. 2010. PMID: 20546697 Free PMC article. Review.
-
Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs.Clin Exp Immunol. 1994 Apr;96(1):91-7. doi: 10.1111/j.1365-2249.1994.tb06236.x. Clin Exp Immunol. 1994. PMID: 8149673 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous